This inventor holds 1 USPTO granted patent. Top assignees: Chiba University, University of California. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 156 
1 out of 16,035 
Years Active: 2025
Title: Innovations by Qian Ren in Cognitive Disease Research
Introduction
Qian Ren is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of cognitive disease research, particularly in relation to alpha-synuclein aggregates. His work aims to address critical health issues such as Parkinson's Disease and Dementia with Lewy Bodies.
Latest Patents
Qian Ren holds a patent titled "Methods of inhibiting formation of alpha synuclein aggregates." This patent provides methods for preventing, delaying, mitigating, reducing, and inhibiting alpha-synuclein aggregates in the brains of subjects at risk of developing cognitive diseases associated with these aggregates. The implications of this research are profound, as it targets conditions that severely impact cognitive function.
Career Highlights
Throughout his career, Qian Ren has been associated with prestigious institutions such as the University of California and Chiba University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Qian Ren has collaborated with esteemed colleagues, including Bruce D. Hammock and Sung Hee Hwang. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
Qian Ren's innovative approaches to inhibiting alpha-synuclein aggregates represent a significant advancement in the fight against cognitive diseases. His contributions are vital for future research and potential treatments in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile